Hemostemix Inc. HMTXF
0.04 USD 0.00 (-10.49%)
At closeNov 3, 2026, 4:00 PM EST
0.0366 Day range 0.0366
0.035 52-week range 0.07618
- YTD
- -41.44%
- 1 year
- -42.36%
- Market cap
- 7.74M
- EPS (ttm)
- -0.02
- YTD return
- -41.44%
- 1-year return
- -42.36%
- Volume
- 27.00K
- Avg volume
- 4.42K
- Open
- 0.0366
- Previous close
- 0.04089
- Day's range
- 0.0366 – 0.0366
- 52-week range
- 0.035 – 0.07618
2Y -0.0325 (-46.99%)
News
Hemostemix Announces Full LARTA Approval, Manufacturing Progress and Financing Update 
Hemostemix to Attend Centurion One Capital's 4th Annual Bahamas Summit 
Hemostemix Non Brokered Private Placement 
Hemostemix Commercializes Its Vascular Dementia Clinical Trial of VesCell(TM) Under LARTA 
Dr. Ernst von Schwarz, Principal Investigator of Hemostemix VesCell(TM) Longevity Clinical Trial 
Hemostemix Closes Second Tranche of Private Placement and Obtains Extension to August 14, 2026 
Hemostemix' Longevity Phase I Clinical Trial Leveraging VesCell(TM)'s Excellent Results 
Hemostemix Grants Stock Options 
Commercialization Application Filed by Hemostemix for the Treatment of Vascular Dementia, Angina and Pain 
Hemostemix Closes $360,000 First Tranche of Private Placement
Your note
Sign in to keep a note on HMTXF — it syncs with the Stock Master app.